No Data
No Data
Sichuan Hebang Biotechnology (603077.SH): The company's project in Indonesia has recently commenced.
Golden Union News on November 15th: Sichuan Hebang Biotechnology (603077.SH) stated on the investor interaction platform that 1. The company's Indonesia project has recently started. 2. Since 2024, the caustic soda market has been under pressure due to increased capacity and declining downstream demand, leading to continuous price declines and exceptionally fierce market competition. As one of the only three caustic soda production and sales companies in the southwest region, the company has invested in Chongqing Heyou, optimizing the downstream customers and channels, improving the competitive environment of the caustic soda business, and helping stabilize sales prices in the caustic soda market, avoiding unnecessary vicious competition, which is beneficial to both parties. 3. Your suggestion.
Sichuan Hebang Biotechnology (603077.SH): "Hebang Convertible Bonds" will start trading on November 19th.
Sichuan Hebang Biotechnology (603077.SH) announced that the company's issuance of 4.6 billion yuan convertible bonds will be...
Here's What's Concerning About Sichuan Hebang Biotechnology's (SHSE:603077) Returns On Capital
Sichuan Hebang Biotechnology Secures 140-Million-Yuan Loan for Share Buyback
Sichuan Hebang Biotechnology (603077.SH): has actually repurchased 0.70% of the company's shares.
Gelonghui November 1st | sichuan hebang biotechnology (603077.SH) announced that on November 1, 2024, the company completed this repurchase. This time, a total of 62,181,660 shares were repurchased, accounting for 0.70% of the company's total share capital. The highest repurchase price was 1.72 yuan/share, the lowest repurchase price was 1.64 yuan/share, the average repurchase price was 1.67 yuan/share, and the total amount of funds used was 103,995,776.75 yuan.
Hebang Biotech: Hebang Biotech Report for the Third Quarter of 2024
No Data
No Data